Zobrazeno 1 - 10
of 15
pro vyhledávání: '"M. A. Dodokhova"'
Autor:
M. A. Dodokhova, O. V. Voronova, I. M. Kotieva, A. V. Safronenko, S. V. Shlyk, N. V. Drobotya, M. A. Akimenko, D. B. Shpakovsky, E. R. Milaeva
Publikováno v:
The Siberian Journal of Clinical and Experimental Medicine. 38:167-174
Introduction. Organotin compounds are promising candidates for antitumor drugs. Identification of pathogenetic features of the general toxic effect of hybrid organotin compounds during the period of the greatest severity of the intoxication clinical
Autor:
I. M. Kotieva, E. M. Frantsiyants, S. V. Shlyk, N. V. Drobotya, M. V. Gulyan, M. A. Dodokhova
Publikováno v:
The Siberian Journal of Clinical and Experimental Medicine. 38:133-139
Introduction. Chronic pain syndrome in the development of malignant neoplasms has a complex polyethological character. The study of the pathogenetic mechanisms of pain during the growth of the transplanted tumor in the experiment can open up broad pe
Autor:
E. R. Milaeva, D. B. Shpakovsky, E. V. Radchenko, V. A. Palyulin, D. A. Babkov, A. V. Borisov, M. A. Dodokhova, A. V. Safronenko, I. M. Kotieva, A. A. Spasov
Publikováno v:
Russian Chemical Bulletin. 71:2605-2611
Autor:
M. A. Dodokhova, I. M. Kotieva, A. V. Safronenko, S. V. Shlyk, N. V. Drobotya, D. B. Shpakovsky
Publikováno v:
South Russian Journal of Therapeutic Practice. 3:25-31
The search for new antitumor and antimetastatic therapy targets is a priority task for interdisciplinary research in medical chemistry, experimental pharmacology and pathological physiology. One of the promising scopes of research in this direction i
Autor:
M. A. Dodokhova, I. M. Kotieva, A. V. Safronenko, M. S. Alkhusein-Kulyaginova, N. V. Sukhorukova, V. M. Kotieva, E. M. Kotieva, S. I. Starostin, D. B. Shpakovsky, E. A. Nikitin, E. R. Milaeva
Publikováno v:
Bulletin of Experimental Biology and Medicine. 173:620-622
Autor:
M. A. Dodokhova, I. M. Kotieva, A. V. Safronenko, M. S. Alkhusein-Kulyaginova, N. V. Sukhorukova, V. M. Kotieva, Е. M. Kotieva, D. B. Shpakovsky, E. A. Nikitin, E. R. Milaeva
Publikováno v:
Bulletin of Experimental Biology and Medicine. 172:752-755
Autor:
M. A. Dodokhova, A. V. Safronenko, I. M. Kotieva, M. S. Alkhuseyn-Kulyaginova, E. R. Milaeva, D. B. Shpakovsky, Yu. M. Makarenko, A. Yu. Terekhov, E. O. Sergeeva
Publikováno v:
Crimea Journal of Experimental and Clinical Medicine. 11:11-18
The most important task of preclinical research of promising candidates for antitumor drugs is to assess the safety of their use. The study of the cardiotoxicity of organotin compounds (OOS) dimethyltin bis (3,5-di-tert-butyl-4-hydroxy- phenylthiolat
Autor:
V. G. Trepel, A. V. Safronenko, Elena R. Milaeva, M. A. Dodokhova, Ekaterina Fedorovna Komarova, I. M. Kotieva, D. B. Shpakovskiy, M. S. Alkhuseyn-Kulyaginova
Publikováno v:
Ural Medical Journal. 20:73-77
The aim of the study was to evaluate the safety of the use of organotin compounds containing a fragment of 2,6-di-tert-butylphenol as pharmaceutical substances when administered intragastrically to Wistar outbred rats (females). Material and methods.
Autor:
D. B. Shpakovskiy, Elena R. Milaeva, V. G. Trepel, M. A. Dodokhova, M. S. Alkhuseyn–Kulyaginova, А. V. Safronenko, I. M. Kotieva
Publikováno v:
Ural Medical Journal. 20:18-23
Introduction. The aim of the study was to evaluate the effect of hybrid organotin compounds bis(3,5–di– tert–butyl–4–hydroxyphenylthiolate) dimethylol (Me3) and ((3,5–di–tert–butyl–4–hydroxyphenylthiolate) triphenylolol (Me5) on t
Autor:
Elena R. Milaeva, I. M. Kotieva, M. A. Dodokhova, D.B. Shpakovsky, T.A. Antonenko, E. V. Gantsgorn, Ekaterina Fedorovna Komarova, M. S. Alkhuseyn-Kulyaginova, A. V. Safronenko
Publikováno v:
Journal Biomed. 17:88-99
This review analyzed the literature data on the in vitro preclinical study of the cytotoxic properties of organotin compounds, as well as the main mechanisms of their action. The latter consist in interacting with SH groups of proteins, initiating ox